Tuberculosis remains an important factor in the morbidity and mortality of hemodialysis patients

Transplant Proc. 1998 May;30(3):846-7. doi: 10.1016/s0041-1345(98)00073-6.
No abstract available

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Morbidity
  • Polymerase Chain Reaction
  • Renal Dialysis / adverse effects*
  • Renal Dialysis / mortality
  • Tuberculosis / diagnosis
  • Tuberculosis / drug therapy
  • Tuberculosis / epidemiology*
  • Tuberculosis / mortality

Substances

  • Antitubercular Agents